These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7292431

  • 1. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)].
    Fromantin M, Gautier D, Quatre JM, Bon R.
    Therapie; 1981; 36(4):473-6. PubMed ID: 7292431
    [No Abstract] [Full Text] [Related]

  • 2. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU, Schleicher E, Renner R, Mehnert H.
    MMW Munch Med Wochenschr; 1983 Sep 02; 125(35):751-3. PubMed ID: 6415427
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H, Pometta D, Gustafson A.
    Nouv Presse Med; 1980 Dec 22; 9(49):3759-62. PubMed ID: 7208343
    [Abstract] [Full Text] [Related]

  • 4. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J, Sauvanet JP, Chanu B, Bakir R, Goy-Loeper J, Saya C, Pinaroli F.
    Nouv Presse Med; 1980 Dec 22; 9(49):3747-51. PubMed ID: 7208341
    [Abstract] [Full Text] [Related]

  • 5. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C, Heller F, Desager JP.
    Artery; 1980 Dec 22; 7(1):73-82. PubMed ID: 7247733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
    Ceska R, Sobra J, Procházková R, Kvasilová M.
    Vnitr Lek; 1990 Apr 22; 36(4):363-7. PubMed ID: 2356612
    [Abstract] [Full Text] [Related]

  • 13. [Muscular toxicity due to fenofibrate. Apropos of a case].
    Giraud P, Cassou M, Paul R, Guidet M.
    Rev Rhum Mal Osteoartic; 1982 Feb 22; 49(2):162. PubMed ID: 7063798
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative research on etofibrate retard and fenofibrate in hyperlipoproteinemia].
    Schwartzkopff W, Schilling A.
    Med Welt; 1980 Dec 12; 31(50):1845-50. PubMed ID: 7464535
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.